
ViaCyte on the Rise: First Diabetes Trial Data & Acquires BetaLogics IP
Clinical research on Type I Diabetes is one of the most exciting and promising areas of stem cells and regenerative medicine for human disease. Two of the coolest companies out there in this arena have been ViaCyte and BetaLogics (owned […]